Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.510
+0.030 (2.03%)
Jun 6, 2025, 4:00 PM - Market closed

Sunshine Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
56714305
Upgrade
Market Cap Growth
-36.52%-13.95%-51.77%-52.26%480.17%1941.74%
Upgrade
Enterprise Value
-2-6-11-26326
Upgrade
Last Close Price
1.513.00543.001280.0023380.006280.00
Upgrade
PS Ratio
0.050.170.293.33132.5573.08
Upgrade
PB Ratio
0.180.260.330.67143.04-5.47
Upgrade
P/TBV Ratio
0.280.290.350.69271.15-
Upgrade
EV/Sales Ratio
----137.9881.76
Upgrade
Debt / Equity Ratio
0.040.040.030.048.98-2.00
Upgrade
Asset Turnover
1.191.200.850.280.140.13
Upgrade
Inventory Turnover
2.582.853.491.561.821.30
Upgrade
Quick Ratio
2.022.153.393.4322.590.95
Upgrade
Current Ratio
4.254.114.483.9424.070.98
Upgrade
Return on Equity (ROE)
-21.17%-22.97%-21.04%-244.92%--
Upgrade
Return on Assets (ROA)
-11.78%-12.55%-10.57%-34.48%-93.90%-63.05%
Upgrade
Return on Capital (ROIC)
-14.67%-15.68%-13.51%-44.25%-99.36%-76.84%
Upgrade
Earnings Yield
-91.62%-85.58%-64.63%-185.03%-41.08%-53.35%
Upgrade
FCF Yield
-230.62%-236.51%-127.05%-37.65%-6.04%-12.62%
Upgrade
Buyback Yield / Dilution
-614.35%-5371.73%----
Upgrade
Updated Apr 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q